The estimated Net Worth of Peter Powchik is at least $24.8 million dollars as of 16 December 2015. Peter Powchik owns over 1,921 units of Regeneron Pharmaceuticals stock worth over $20,251,606 and over the last 18 years Peter sold REGN stock worth over $4,567,089.
Peter has made over 18 trades of the Regeneron Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently Peter exercised 1,921 units of REGN stock worth $99,950 on 16 December 2015.
The largest trade Peter's ever made was exercising 109,866 units of Regeneron Pharmaceuticals stock on 21 February 2012 worth over $1,988,575. On average, Peter trades about 16,684 units every 57 days since 2006. As of 16 December 2015 Peter still owns at least 17,742 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Peter Powchik stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis et Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: